Friday, September 26, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Salesforce Shares Face Pressure Despite Solid Fundamentals

Andreas Sommer by Andreas Sommer
September 26, 2025
in AI & Quantum Computing, Analysis, Earnings, Tech & Software
0
Salesforce Stock
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

Salesforce finds itself navigating a challenging market environment. The customer relationship management leader recently posted impressive quarterly figures, including a 10% revenue increase, yet its stock continues a persistent downward trajectory. The central concern among investors is the apparent delay in monetizing the company’s multi-billion dollar artificial intelligence initiatives. While the long-term potential is widely acknowledged, the market is growing impatient for tangible financial results from the AI push.

Strong Earnings Overshadowed by Cautious Outlook

The paradox for Salesforce is stark. For the second quarter of its 2026 fiscal year, the company announced robust performance, surpassing expectations with revenues of $10.2 billion. Its adjusted earnings per share came in at $2.91, notably higher than most analyst forecasts. Despite these strong fundamentals, the equity has been under significant selling pressure.

This negative trend continued recently, with shares dropping another 2% in a single Thursday session. Since the start of the year, the stock has declined by a substantial 27.5 percent. The primary trigger for the latest sell-off was the company’s guidance for the upcoming third quarter. Salesforce projected revenues in the range of $10.24 to $10.29 billion. The midpoint of this forecast fell short of the more optimistic numbers anticipated on Wall Street, causing a sharp decline in after-hours trading.

The AI Monetization Question

The core issue fueling investor skepticism is the pace at which Salesforce’s highly publicized AI investments are contributing to the bottom line. CEO Marc Benioff has been a vocal proponent of the technology’s transformative impact. However, specific revenue contributions from new AI-driven products, such as the “Agentforce” platform, have yet to materialize in a significant way within the company’s financial statements. The subdued forecast has intensified doubts about the timeline for AI to become a major growth driver.

Should investors sell immediately? Or is it worth buying Salesforce?

A Divided Analytical Community

Market experts remain divided in their assessment of Salesforce’s prospects. On one hand, analysts like Patrick Walravens from Citizens JMP maintain a bullish stance, recently reaffirming a “Buy” rating with a price target of $430. This optimism is rooted in the belief in the vast potential embedded within Salesforce’s AI ecosystem.

Conversely, other firms advocate for caution. Macquarie, for instance, holds a “Neutral” rating with a more conservative price target of $250. The overall analyst consensus, which currently comprises 30 “Buy” recommendations, eight “Hold” ratings, and a single “Sell” recommendation, points to a “moderate Buy” sentiment.

The fundamental challenge for investors remains unchanged. The long-term opportunity presented by AI is not in dispute, but the short-term execution appears to be lagging behind the ambitious expectations set by the company. The market is now forced to weigh whether the current price represents a buying opportunity for a long-term AI bet or if expectations need to be reset for the foreseeable future.

Ad

Salesforce Stock: Buy or Sell?! New Salesforce Analysis from September 26 delivers the answer:

The latest Salesforce figures speak for themselves: Urgent action needed for Salesforce investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 26.

Salesforce: Buy or sell? Read more here...

Tags: Salesforce
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Delta Air Lines Stock
Analysis

Delta Air Lines Navigates Strategic Shift Amid Steady Dividend Payouts

September 26, 2025
Upstart Holdings Stock
Analysis

Upstart Holdings Shares Slide Despite Impressive Quarterly Performance

September 26, 2025
Deckers Outdoor Stock
Analysis

Analyst Confidence in Deckers Outdoor Defies Stock Price Decline

September 26, 2025
Next Post
Meta Stock

A Day of Extremes for Meta: Regulatory Storm Clouds as Threads Overtakes X

Pfizer Stock

Pfizer Bets Billions on Obesity Market Entry with Metsera Acquisition

UPS Stock

UPS Shares Plunge to Lowest Point in a Year

Recommended

Kraft Heinz Stock

Could a Corporate Split Revitalize Kraft Heinz?

4 weeks ago
Unlocking Value: The Economic Potential of Iron-Titanium-Vanadium Projects

Reminder Deadline to Purchase Miller Industries Shares for Dividend Distribution Approaching

2 years ago
Clearside Biomedical Stock

Clearside Biomedical Shares Surge on Promising Clinical Data

4 hours ago

Analyst Upgrades Sweetgreen Price Target to 19

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

US Government’s Lithium Sector Move Sparks Albemarle Rally

Analyst Confidence in Deckers Outdoor Defies Stock Price Decline

BAE Systems Navigates Labor Challenges Amid Record Contract Backlog

Zoetis Shares Face Market Pressure Despite Product Breakthroughs

Centrus Energy’s Nuclear Ambitions Fueled by Major Expansion Plan

XPeng Accelerates Southeast Asian Expansion with Major Charging Partnership

Trending

Reviva Pharmaceuticals Holdings Stock
Penny Stocks

Reviva Pharmaceuticals Shares Plummet Following Equity Offering

by Andreas Sommer
September 26, 2025
0

Reviva Pharmaceuticals Holdings (RVPH) is experiencing a severe downturn as investor sentiment sours. The dual pressures of...

Delta Air Lines Stock

Delta Air Lines Navigates Strategic Shift Amid Steady Dividend Payouts

September 26, 2025
Upstart Holdings Stock

Upstart Holdings Shares Slide Despite Impressive Quarterly Performance

September 26, 2025
Albemarle Stock

US Government’s Lithium Sector Move Sparks Albemarle Rally

September 26, 2025
Deckers Outdoor Stock

Analyst Confidence in Deckers Outdoor Defies Stock Price Decline

September 26, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Reviva Pharmaceuticals Shares Plummet Following Equity Offering
  • Delta Air Lines Navigates Strategic Shift Amid Steady Dividend Payouts
  • Upstart Holdings Shares Slide Despite Impressive Quarterly Performance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com